# Galaxy Surfactants share price today (Galaxy Surfactants Ltd, NSE: GALAXYSURF)

> Galaxy Surfactants share price today: ₹2,246.60 at the NSE close on 3 November 2026, up 0.7% in a year. Galaxy Surfactants (NSE: GALAXYSURF) is worth ₹7,965 crore, trades at a P/E of 21.9 and has closed between ₹1,597.10 and ₹2,508.40 over the past 52 weeks. > Galaxy Surfactants Ltd's results are improving, while its P/E is near the low end of its own history over 8.7 years, higher than only 10% of past readings. GALAXYSURF · Speciality Chemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: ₹2,246.60 (+0.7% in a year)
- P/E: 21.9× (lower than 90% of the last 8.7 years)
- Revenue (Jun 2026): ₹1,782 Cr (+39.4% on a year ago)
- Profit (Jun 2026): ₹166 Cr (+110.1% on a year ago)
- Operating margin: 14.0% (+4.0 points on a year ago)
- ROCE: 14%, FY26
- ROIC: 17.0%, against a 12.0% cost of capital: +5.0 points

Biggest thing to watch: the price has already been rising for 11 weeks, so timing is the risk more than the business. ## What is the Galaxy Surfactants share price today? Galaxy Surfactants Ltd's share price was ₹2,246.60 at the close on 3 November 2026. It has been rising for 11 weeks. That is 6.4% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹1,597 and ₹2,508, and at that close it sat 71% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 1 week running. Over the last 8.7 years the share price moved +35% while the NIFTY 500 moved +135%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 30 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Galaxy Surfactants this quarter? Three changes stood out: profit grew again in the June 2026 quarter, best operating margin in 13 quarters and revenue up on a year earlier for 9 quarters in a row. 1. Profit grew again in the June 2026 quarter Profit was ₹166 crore, +110.1% on a year earlier (₹79 crore), after 6 quarters of decline. Why: Profit rose because the company made much more profit on each tonne it sold, and demand came back in India after reformulation had hurt it. Next results: check whether profit per tonne stays near the lower quarterly path management set for the next three quarters. From the earnings call on 14 Aug 2026. 2. Best operating margin in 13 quarters Operating margin was 14% in the June 2026 quarter, against 10% a year earlier. Why: Margin rose because more sales came from higher-value specialty products and the company was stricter on pricing, inventory and costs. Next results: check whether the margin holds without help from one-off inventory gains or a sudden finished-product price spike. From the earnings call on 14 Aug 2026. 3. Revenue up on a year earlier for 9 quarters in a row In the June 2026 quarter revenue was ₹1,782 crore, +39.4% on a year earlier. Why: Revenue rose because selling prices were higher, partly because export freight costs more than doubled and the mix of product forms changed. Next results: check that demand in India holds and Egypt supply stays steady, with no new geopolitical shock. From the earnings call on 14 Aug 2026. ## What are Galaxy Surfactants' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Galaxy Surfactants reported revenue of ₹1,782 crore, up 39.4% from ₹1,278 crore a year earlier, and a profit of ₹166 crore, up 110.1% from ₹79.0 crore. ### Galaxy Surfactants results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹1,782 crore | ₹1,278 crore | +39.4% |
| Profit | ₹166 crore | ₹79.0 crore | +110.1% |
| Earnings per share | ₹46.80 | ₹22.42 | +108.7% |
| Operating margin | 14.0% | 10.0% | +4.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Galaxy Surfactants' management discussed these results on a call held on 14 August 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Galaxy Surfactants share price history? Galaxy Surfactants closed at ₹2,246.60 on 3 November 2026, up 0.7% from ₹2,230.50 a year earlier (31 October 2025) and down 27.3% over five years. Its highest weekly close since February 2018 was ₹3,404.45 on 14 October 2021. ### Galaxy Surfactants share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹2,221.60 | +1.1% |
| 1 month ago · 1 Oct 2026 | ₹2,376.90 | −5.5% |
| 6 months ago · 30 Apr 2026 | ₹1,857.20 | +21.0% |
| 1 year ago · 31 Oct 2025 | ₹2,230.50 | +0.7% |
| 3 years ago · 3 Nov 2023 | ₹2,847.15 | −21.1% |
| 5 years ago · 4 Nov 2021 | ₹3,090.25 | −27.3% |
| Earliest weekly close in our records · 9 Feb 2018 | ₹1,665.95 | +34.9% |
| Highest weekly close since February 2018 · 14 Oct 2021 | ₹3,404.45 | −34.0% |
| Lowest weekly close since February 2018 · 15 Feb 2019 | ₹900.90 | +149.4% |
| 52-week high (weekly close) · 14 Aug 2026 | ₹2,508.40 | −10.4% |
| 52-week low (weekly close) · 27 Mar 2026 | ₹1,597.10 | +40.7% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (461 weekly closes from 9 February 2018 to 3 November 2026.)

## What is the latest news on Galaxy Surfactants? 3 Nov 2026: Galaxy Surfactants closed at ₹2,246.60, up 1.1% on the week and down 5.5% on the month. 14 Aug 2026: Galaxy Surfactants held its results call for April to June 2026. Management guided: FY27 consolidated volume growth 6-8% and operating profit per metric ton ₹24,000-25,000; operating profit/MT guidance raised from ₹19,000-21,000. ### Earlier

- 31 Jul 2026: ex-date for a dividend of ₹22 a share. - Results for April to June 2026: Revenue up 39.4% and profit up 110.1% on a year earlier. ## What dividend does Galaxy Surfactants pay? Galaxy Surfactants paid ₹22 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 0.98% at the ₹2,246.60 close on 3 November 2026. The last was a dividend of ₹22 a share, ex-date 31 July 2026. ### Galaxy Surfactants dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 31 Jul 2026 | ₹22 | Dividend | same day |
| 1 Aug 2025 | ₹4 | Dividend | same day |
| 20 Mar 2025 | ₹18 | Interim | same day |
| 26 Jul 2024 | ₹22 | Dividend | same day |
| 28 Jul 2023 | ₹4 | Dividend | same day |
| 20 Feb 2023 | ₹18 | Interim | same day |
| 21 Jul 2022 | ₹18 | Dividend | 22 Jul 2022 |
| 31 Aug 2021 | ₹4 | Dividend | 1 Sep 2021 |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Galaxy Surfactants Ltd paid out 29% of its profit as dividends in FY26, and it paid a dividend in each of its last 12 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Galaxy Surfactants management say on the latest results call? On the call for April to June 2026, held on 14 August 2026, Galaxy Surfactants' management guided: FY27 consolidated volume growth 6-8% and operating profit per metric ton ₹24,000-25,000; operating profit/MT guidance raised from ₹19,000-21,000. > “As regards our guidance for the full year, we maintain our volume guidance at 6-8% for the full year FY27. However, I am increasing the range of the EBITDA per metric ton guidance from the current 19,000 to 21,000 per metric ton to 24,000 to 25,000 per metric ton.”
> K. Natarajan, Managing Director, on the call for April to June 2026

### What management guided

- Next three quarters: sustainable quarterly operating profit per metric ton approximately ₹21,000-22,000. - Near-term fatty alcohol prices expected to move sideways within USD 2,600-2,800 CIF India. - Mexico EPC project commercialization on track over the next 12 months. - EPC service-income recognition to complete by FY27 year-end. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/5643/Conference Call/CC-Aug26.pdf). (From the call for April to June 2026, 14 August 2026.)

## What to watch in Galaxy Surfactants' next results? When Galaxy Surfactants reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Volume momentum to sustain through the festive season - check India demand, Egypt supply continuity and absence of another geopolitical shock. - What to check (from the call)
- Volume momentum to sustain through the festive season - check India demand, Egypt supply continuity and absence of another geopolitical shock. - Operating profit/MT to remain near the guided quarterly path - check whether it lasts without isolated inventory or finished-product price effects. - AMET order-book recovery to convert into year-on-year growth - check supply normalization and diversification offsetting local Egypt share loss. - Fatty alcohol prices to remain within the stated near-term band - check reformulation economics and margin stability. ## Which stock lists is Galaxy Surfactants on? Galaxy Surfactants is not on any of our India lists this week. ## Is Galaxy Surfactants profitable? Galaxy Surfactants Ltd earned ₹166 Cr of net profit in the Jun 2026 quarter, +110.1% on the same quarter a year earlier. Full-year FY26 profit was ₹267 Cr. Over 10 years profit has grown 10.0% a year on average. That is 9.3% of the quarter's revenue. The same quarter a year earlier earned ₹79.0 Cr. For the full year, FY26 profit was ₹267 Cr (−12.5% on the year before). Why profit moved: revenue changed +39.4% on a year earlier and the margin moved +4.0 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +15.0% and revenue +26.6%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Galaxy Surfactants make, and is it growing? Galaxy Surfactants Ltd reported ₹1,782 Cr of revenue in the Jun 2026 quarter, +39.4% on the same quarter a year earlier. That is the 9th quarter in a row with growth on the year before. Over 10 years it has grown 11.3% a year on average. The last full year, FY26, came in at ₹5,245 Cr. The last four reported quarters add to ₹5,752 Cr. FY26 revenue was ₹5,245 Cr, +24.3% on the year before. Recent pace: the last four quarters grew +26.6% on average, against 11.3% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +27.0%, against +22.6% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +15.7%, against +7.4% a year (accelerating). ## How much of every ₹100 of sales does Galaxy Surfactants keep? Galaxy Surfactants Ltd's operating margin was 14.0% in the Jun 2026 quarter, 4.0 percentage points higher than the same quarter a year ago. Across 12 years it has been between 9.0% and 16.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +4.3 percentage points on the year while gross margin changed +3.0 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Galaxy Surfactants' profit turning into cash? Over the last 3 years, 146% of Galaxy Surfactants Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹333 Cr of operating cash against ₹267 Cr of profit. After ₹186 Cr of spending on assets, ₹147 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 146% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle. What to look at next: the bigger use of cash is spending on new assets, at 1.9× depreciation over three years. The next section checks what that spending is building. ## Where does Galaxy Surfactants' cash go? Galaxy Surfactants Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 66 days in FY26, down from 72 days in FY21. It spent ₹626 Cr on assets over the last 3 years. Customers take 52 days to pay, and stock sits for 76 days on average. At FY26 sales of ₹5,245 Cr, each day of that cycle ties up about ₹14.4 Cr, so roughly ₹948 Cr is tied up in the business at any time. FY26: customers took 52 days to pay and stock sat for 76 days, about 2.5 months of sales sitting as stock, for a full cycle of 66 days, shorter than FY21's 72. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 76 days. Customers pay about 52 days after that. Suppliers are paid at 62 days. Together that makes the 66-day cycle. Spending on assets: ₹626 Cr over the last 3 years, against ₹333 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹181 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Galaxy Surfactants' P/E ratio, and how does it compare with its own history? Galaxy Surfactants Ltd's P/E is 21.9×, near the low end of its own history: it has been lower only 10% of the time. Its usual P/E (the middle reading) is 26.7×, over 8.7 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹99.79. Why the multiple is where it is: over the past year earnings per share moved −12.3% while the price moved +0.7%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved −6.2% a year; about +2.4% a year came from earnings growth and about −8.6 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Galaxy Surfactants business getting better or worse? Galaxy Surfactants Ltd's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE rising at 17.7%; each line tells part of the story. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Galaxy Surfactants earn on its capital? Galaxy Surfactants Ltd earned a ROCE of 14% in FY26. Its return on capital used (ROIC) is 5.0 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 5.1% net margin and 1.36× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 5.1% net margin × 1.36× asset turnover × 1.41× leverage (assets divided by equity) ≈ 9.8% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 17.0% − 12.0% = +5.0 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 17.0% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 13.2%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Galaxy Surfactants have too much debt? Galaxy Surfactants Ltd has total debt of ₹235 Cr against shareholder equity of ₹2,745 Cr as of Jun 2026, so its debt is 0.09× its equity, which is very little. Year by year, that ratio went from 0.27 in FY22 to 0.09 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Galaxy Surfactants shareholding pattern? No group of Galaxy Surfactants Ltd's owners changed its stake by a full percentage point over the last two years. Domestic institutions moved +0.1 points over the same period, to 13.1%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −0.1 points over 8 quarters, to 3.9%; Domestic institutions: +0.1 points over 8 quarters, to 13.1%; Promoters: +0.0 points over 8 quarters, to 70.9%. ## How far is Galaxy Surfactants from balance-sheet trouble? For Galaxy Surfactants Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Galaxy Surfactants rank in its industry? 53.9 out of 100, rank 12 of 30 in Speciality Chemicals, with 81% of the evidence available. Galaxy Surfactants Ltd scores 53.9 out of 100 against the 30 companies it is compared with in Speciality Chemicals, ranking 12. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 21.9 + 12.3 + 8.3 + 11.4 = 53.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Galaxy Surfactants compared with? Galaxy Surfactants ranks 12 of 30 Speciality Chemicals companies on the 4-Factor Sector Score, with 53.9 out of 100. 1. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) PANAMAPET · turning · Sector-leading setup · 96% evidence 80.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.8/35 · Revenue 45.9% · Profit 100% · Operating margin change 14 points · 88% evidence Capital efficiency 15.9/25 · ROCE 19.2% · Operating margin 22% · 100% evidence Valuation 19.7/20 · P/E 5.7× · PEG 0.18 · 100% evidence Relative strength 13.9/20 · Lead over its industry 16.3% · Lead over NIFTY 500 31.3% · 1 year 68.1% · 100% evidence · 10 of 12 weeks ahead Exact sum: 30.8 + 15.9 + 19.7 + 13.9 = 80.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) YASHO · losing its lead · Most evidence points up · 78% evidence 67.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.0/35 · Revenue 54.2% · Profit 100% · Operating margin change 3 points · 100% evidence Capital efficiency 12.3/25 · ROCE 8.9% · Operating margin 21% · 100% evidence Valuation 12.7/20 · P/E 45× · PEG 1.02 · 65% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 41.1% · 1 year 103.4% · 25% evidence · 11 of 12 weeks ahead Exact sum: 30 + 12.3 + 12.7 + 12.2 = 67.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) breaking out · Evidence leans up · 68% evidence 64.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 16.9% · Profit 41.9% · Operating margin change 8 points · 83% evidence Capital efficiency 21.3/25 · ROCE 36.2% · Operating margin 48% · 95% evidence Valuation 6.6/20 · P/E 25.8× · PEG n/a · 50% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 74.5% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.8 + 21.3 + 6.6 + 12.5 = 64.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Sunshield Chemicals Ltd](https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd) SUNSHIEL · quiet · Evidence leans up · 81% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 12.9% · Profit 100% · Operating margin change 5 points · 88% evidence Capital efficiency 18.8/25 · ROCE 19.9% · Operating margin 16% · 100% evidence Valuation 10.8/20 · P/E 24.3× · PEG 2.21 · 100% evidence Relative strength 10.8/20 · Lead over its industry n/a · Lead over NIFTY 500 4.3% · 1 year -4% · 25% evidence · 0 of 5 weeks ahead Exact sum: 23.6 + 18.8 + 10.8 + 10.8 = 64 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) BLACKROSE · quiet · Evidence leans up · 81% evidence 60.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 8.6% · Profit 28.6% · Operating margin change 6 points · 88% evidence Capital efficiency 16.4/25 · ROCE 18.7% · Operating margin 16% · 100% evidence Valuation 10.0/20 · P/E 17.1× · PEG 4.96 · 100% evidence Relative strength 10.9/20 · Lead over its industry n/a · Lead over NIFTY 500 4.4% · 1 year n/a · 25% evidence · 7 of 12 weeks ahead Exact sum: 23.6 + 16.4 + 10 + 10.9 = 60.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) TATVA · losing its lead · Evidence leans up · 93% evidence 60.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.7/35 · Revenue 49.2% · Profit 100% · Operating margin change 1 points · 100% evidence Capital efficiency 8.7/25 · ROCE 7.2% · Operating margin 19% · 100% evidence Valuation 11.3/20 · P/E 60.2× · PEG 1.21 · 65% evidence Relative strength 11.4/20 · Lead over its industry 7.8% · Lead over NIFTY 500 23.3% · 1 year 15.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 28.7 + 8.7 + 11.3 + 11.4 = 60.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Aether Industries Ltd](https://www.sectoralpha.in/stocks/aether-industries-ltd) AETHER · leader · Evidence leans up · 90% evidence 59.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 30.2% · Profit 28.4% · Operating margin change 1 points · 100% evidence Capital efficiency 12.8/25 · ROCE 11.9% · Operating margin 32% · 100% evidence Valuation 9.7/20 · P/E 85.1× · PEG n/a · 50% evidence Relative strength 14.8/20 · Lead over its industry 22.3% · Lead over NIFTY 500 38.6% · 1 year 114.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 22.4 + 12.8 + 9.7 + 14.8 = 59.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) PRIVISCL · quiet · Evidence leans up · 82% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 17.5% · Profit 44.5% · Operating margin change -1 points · 95% evidence Capital efficiency 18.5/25 · ROCE 22.3% · Operating margin 26% · 76% evidence Valuation 10.1/20 · P/E 33.7× · PEG n/a · 50% evidence Relative strength 7.1/20 · Lead over its industry -9.7% · Lead over NIFTY 500 4.2% · 1 year 10.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 23.7 + 18.5 + 10.1 + 7.1 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fineotex Chemical Ltd](https://www.sectoralpha.in/stocks/fineotex-chemical-ltd) FCL · leader · Evidence leans up · 96% evidence 59.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue 91.5% · Profit 41% · Operating margin change -2 points · 88% evidence Capital efficiency 13.5/25 · ROCE 18.3% · Operating margin 16% · 100% evidence Valuation 5.7/20 · P/E 46.1× · PEG 1.92 · 100% evidence Relative strength 19.5/20 · Lead over its industry 34.1% · Lead over NIFTY 500 48.9% · 1 year 62.9% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.3 + 13.5 + 5.7 + 19.5 = 59 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) DMCC · quiet · Evidence leans up · 93% evidence 55.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.9/35 · Revenue 72.1% · Profit 34.5% · Operating margin change -6.9 points · 100% evidence Capital efficiency 8.7/25 · ROCE 14.8% · Operating margin 4.2% · 100% evidence Valuation 16.1/20 · P/E 16.9× · PEG 0.44 · 65% evidence Relative strength 7.8/20 · Lead over its industry -12.3% · Lead over NIFTY 500 0.9% · 1 year -15.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 22.9 + 8.7 + 16.1 + 7.8 = 55.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Aarti Industries Ltd](https://www.sectoralpha.in/stocks/aarti-industries-ltd) AARTIIND · quiet · Evidence leans up · 100% evidence 55.2 out of 100 Growth Capital Valuation Relative
12. Galaxy Surfactants Ltd this page GALAXYSURF · leader · Evidence leans up · 81% evidence 53.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.9/35 · Revenue 27% · Profit 15.7% · Operating margin change 4 points · 88% evidence Capital efficiency 12.3/25 · ROCE 13.5% · Operating margin 14% · 100% evidence Valuation 8.3/20 · P/E 20.6× · PEG 4.39 · 100% evidence Relative strength 11.4/20 · Lead over its industry n/a · Lead over NIFTY 500 11% · 1 year -5.1% · 25% evidence · 12 of 12 weeks ahead Exact sum: 21.9 + 12.3 + 8.3 + 11.4 = 53.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 13. [Pidilite Industries Ltd](https://www.sectoralpha.in/stocks/pidilite-industries-ltd) PIDILITIND · quiet · Evidence leans up · 100% evidence 53.0 out of 100 Growth Capital Valuation Relative
14. [DIC India Ltd](https://www.sectoralpha.in/stocks/dic-india-ltd) DICIND · breaking out · Evidence leans up · 81% evidence 53.0 out of 100 Growth Capital Valuation Relative
15. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) KRONOX · breaking out · Evidence leans up · 74% evidence 51.8 out of 100 Growth Capital Valuation Relative
16. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) NEOGEN · leader · Evidence leans up · 90% evidence 51.5 out of 100 Growth Capital Valuation Relative
17. [Chemcon Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd) CHEMCON · breaking out · Evidence leans up · 85% evidence 51.1 out of 100 Growth Capital Valuation Relative
18. [Alkyl Amines Chemicals Ltd](https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd) ALKYLAMINE · quiet · Evidence leans down · 96% evidence 47.9 out of 100 Growth Capital Valuation Relative
19. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) GRAUWEIL · breaking out · Evidence leans down · 96% evidence 46.3 out of 100 Growth Capital Valuation Relative
20. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) PAUSHAKLTD · losing its lead · Evidence leans down · 85% evidence 45.8 out of 100 Growth Capital Valuation Relative
21. [Innovassynth Technologies (India) Ltd](https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd) breaking out · Too little evidence to rank firmly · 53% evidence 44.0 out of 100 Growth Capital Valuation Relative
22. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ANURAS · turning · Evidence leans down · 78% evidence 43.7 out of 100 Growth Capital Valuation Relative
23. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) PLATIND · turning · Evidence leans down · 81% evidence 42.5 out of 100 Growth Capital Valuation Relative
24. [Vinati Organics Ltd](https://www.sectoralpha.in/stocks/vinati-organics-ltd) VINATIORGA · quiet · Evidence leans down · 82% evidence 42.4 out of 100 Growth Capital Valuation Relative
25. [Amal Ltd](https://www.sectoralpha.in/stocks/amal-ltd) AMAL · quiet · Evidence leans down · 68% evidence 41.5 out of 100 Growth Capital Valuation Relative
26. [Amines & Plasticizers Ltd](https://www.sectoralpha.in/stocks/amines-plasticizers-ltd) AMNPLST · quiet · Evidence leans down · 81% evidence 41.1 out of 100 Growth Capital Valuation Relative
27. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) TRANSPEK · losing its lead · Evidence leans down · 63% evidence 38.6 out of 100 Growth Capital Valuation Relative
28. [Vishnu Chemicals Ltd](https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd) VISHNU · losing its lead · Evidence leans down · 100% evidence 38.4 out of 100 Growth Capital Valuation Relative
29. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) CLEAN · breaking out · Evidence leans down · 85% evidence 38.1 out of 100 Growth Capital Valuation Relative
30. [Thirumalai Chemicals Ltd](https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd) TIRUMALCHM · quiet · Most evidence points down · 68% evidence 27.2 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Speciality Chemicals](https://www.sectoralpha.in/sectors/speciality-chemicals), all 30 compared on one page. ## Which companies are close to Galaxy Surfactants in size? Galaxy Surfactants is the 9th largest of 30 Speciality Chemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Vinati Organics, Alkyl Amines Chemicals and Clean Science & Technology. Just below it: Neogen Chemicals, Fineotex Chemical and Yasho Industries. ### Speciality Chemicals companies close in size

1. [Vinati Organics Ltd](https://www.sectoralpha.in/stocks/vinati-organics-ltd) ₹10,286 crore
2. [Alkyl Amines Chemicals Ltd](https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd) ₹8,132 crore
3. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) ₹7,606 crore
4. Galaxy Surfactants Ltd ₹7,502 crore
5. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) ₹6,523 crore
6. [Fineotex Chemical Ltd](https://www.sectoralpha.in/stocks/fineotex-chemical-ltd) ₹5,635 crore
7. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) ₹3,888 crore

[All 30 Speciality Chemicals companies, largest first](https://www.sectoralpha.in/sectors/speciality-chemicals#all-companies)

### Companies close in size in other industries

1. [Kanohar Electricals Ltd](https://www.sectoralpha.in/stocks/kanohar-electricals-ltd) ₹7,523 crore
2. [GNG Electronics Ltd](https://www.sectoralpha.in/stocks/gng-electronics-ltd) ₹7,518 crore · New age - Platform - E-Retail
3. Galaxy Surfactants Ltd ₹7,502 crore
4. [Gujarat Narmada Valley Fertilizers & Chemicals Ltd](https://www.sectoralpha.in/stocks/gujarat-narmada-valley-fertilizers-chemicals-ltd) ₹7,415 crore · Fertilisers
5. [Reliance Power Ltd](https://www.sectoralpha.in/stocks/reliance-power-ltd) ₹7,407 crore · Power - Generation/Distribution

## What else do people ask about Galaxy Surfactants? ### What is Galaxy Surfactants's share price today? Galaxy Surfactants Ltd's share price is ₹2,246.60, +0.7% over the past year. The whole company is worth ₹7,965 Cr on the market. In the last 52 weeks it traded between ₹1,597 to ₹2,508; today it is 71% of the way up from the low, 6.4% above its 200-day average (as of 3 November 2026). ### What were Galaxy Surfactants's latest quarterly results? Galaxy Surfactants Ltd reported revenue of ₹1,782 Cr and net profit of ₹166 Cr for the Jun 2026 quarter. Revenue rose 39.4% and profit rose 110.1% compared with a year earlier. Earnings per share were ₹46.80. The operating margin was 14.0%, 4.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is Galaxy Surfactants's market cap? Galaxy Surfactants Ltd's market capitalisation is ₹7,965 Cr at a share price of ₹2,246.60. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Galaxy Surfactants performing? Galaxy Surfactants Ltd's share price has been rising for 11 weeks. In its latest quarter, revenue rose 39.4% and profit rose 110.1% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 1 week running (as of 3 November 2026). ### Will Galaxy Surfactants's share price go up? This page does not forecast Galaxy Surfactants Ltd's share price. What it shows instead: the share price is ₹2,246.60, and it has been rising for 11 weeks. Its P/E of 21.9× is higher than 10% of its own last 9 years (as of 3 November 2026). ### Does Galaxy Surfactants have too much debt? No, Galaxy Surfactants Ltd has little debt: its debt is 0.09× its equity, and its operating profit is 15 times its interest bill. FY26 borrowings were ₹235 Cr against equity of ₹2,744 Cr. So the returns on this page come from the business, not borrowed money (as of 3 November 2026). ### Where is Galaxy Surfactants in its business cycle? Galaxy Surfactants Ltd's FY26 operating margin was 9.0%, against a 12-year range of 9.0% to 16.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 14.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Galaxy Surfactants story? Biggest thing to watch: the price has already been rising for 11 weeks, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Galaxy Surfactants a stock worth studying right now? What the numbers show: Galaxy Surfactants Ltd's results are improving, while its P/E is near the low end of its own history over 8.7 years, higher than only 10% of past readings. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Galaxy Surfactants share price forecast for 2026? What management itself guided: FY27 consolidated volume growth 6-8% and operating profit per metric ton ₹24,000-25,000; operating profit/MT guidance raised from ₹19,000-21,000. This is research, not advice. We’re not SEBI-registered.